Company intelligence / Profile preview

NextGen Jane

Oakland, California, United Statesjane.com ↗

Ownership: Private
Development stage: Commercial

Overview

NextGen Jane has developed the Smart Tampon System, a patented at-home collection kit that enables genomic analysis of menstrual blood to detect early markers of endometriosis and other gynecological conditions. The company’s approach aims to provide less invasive diagnostics compared to current surgical standards for diseases like endometriosis. Clinical results are focused on validating the ability of their system to identify disease biomarkers from menstrual samples[1][3].

Therapeutic areas: EndocrinologyWomen's Health
Modalities: DeviceGenomic analysis
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on NextGen Jane.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NextGen Jane.

Explore the full profile